Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Guerrant

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
FEBS Letters|February 20, 2014
The Angiomotins--from discovery to functionSusana Moleirinho, William Guerrant, Joseph L Kissil
Journal of Medicinal Chemistry|January 21, 2012
Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitorsWilliam Guerrant, Vishal Patil, Joshua C Canzoneri, et al.
Current Topics in Medicinal Chemistry|June 12, 2010
Macrocyclic histone deacetylase inhibitorsSandra C Mwakwari, Vishal Patil, William Guerrant, et al.
Bioorganic & Medicinal Chemistry|April 10, 2008
Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap groupPo C Chen, Vishal Patil, William Guerrant, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2013
Dual-acting histone deacetylase-topoisomerase I inhibitorsWilliam Guerrant, Vishal Patil, Joshua C Canzoneri, et al.
Cancer Research|May 25, 2016
YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling AxisWilliam Guerrant, Smitha Kota, Scott Troutman, et al.
Journal of Medicinal Chemistry|December 20, 2008
Non-peptide macrocyclic histone deacetylase inhibitorsAdegboyega K Oyelere, Po C Chen, William Guerrant, et al.
Bioorganic & Medicinal Chemistry|November 17, 2009
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap groupVishal Patil, William Guerrant, Po C Chen, et al.
Journal of Medicinal Chemistry|July 31, 2010
Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeletonSandra C Mwakwari, William Guerrant, Vishal Patil, et al.
Cancer Research|April 6, 2021
Pharmacological Disruption of the Notch1 Transcriptional Complex Inhibits Tumor Growth by Selectively Targeting Cancer Stem CellsAnnamil Alvarez-Trotta, William Guerrant, Luisana Astudillo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
FEBS Letters|February 20, 2014
The Angiomotins--from discovery to functionSusana Moleirinho, William Guerrant, Joseph L Kissil
Journal of Medicinal Chemistry|January 21, 2012
Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitorsWilliam Guerrant, Vishal Patil, Joshua C Canzoneri, et al.
Current Topics in Medicinal Chemistry|June 12, 2010
Macrocyclic histone deacetylase inhibitorsSandra C Mwakwari, Vishal Patil, William Guerrant, et al.
Bioorganic & Medicinal Chemistry|April 10, 2008
Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap groupPo C Chen, Vishal Patil, William Guerrant, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2013
Dual-acting histone deacetylase-topoisomerase I inhibitorsWilliam Guerrant, Vishal Patil, Joshua C Canzoneri, et al.
Cancer Research|May 25, 2016
YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling AxisWilliam Guerrant, Smitha Kota, Scott Troutman, et al.
Journal of Medicinal Chemistry|December 20, 2008
Non-peptide macrocyclic histone deacetylase inhibitorsAdegboyega K Oyelere, Po C Chen, William Guerrant, et al.
Bioorganic & Medicinal Chemistry|November 17, 2009
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap groupVishal Patil, William Guerrant, Po C Chen, et al.
Journal of Medicinal Chemistry|July 31, 2010
Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeletonSandra C Mwakwari, William Guerrant, Vishal Patil, et al.
Cancer Research|April 6, 2021
Pharmacological Disruption of the Notch1 Transcriptional Complex Inhibits Tumor Growth by Selectively Targeting Cancer Stem CellsAnnamil Alvarez-Trotta, William Guerrant, Luisana Astudillo, et al.
Pageof 2